Lupin Gets USFDA Approval for Generic Diabetes Drug
January 4, 2024 19:12
Lupin has received USFDA approval to market a generic medication for type 2 diabetes, a generic equivalent of AstraZeneca's Qtern tablets. The drug will be manufactured at Lupin's Pithampur facility.